Douglas Sheridan, Ph.D.
About Douglas Sheridan, Ph.D.
Douglas Sheridan Ph.D. Education and Expertise
Douglas Sheridan holds a B.S. in biochemistry and molecular biology from Pennsylvania State University. He furthered his education by obtaining a Ph.D. in neuroscience from Yale University. His academic background provides a strong foundation in the fields of biochemistry, molecular biology, and neuroscience, essential for his contributions in drug development and clinical research.
Douglas Sheridan Co-Inventor of Clinical Drug Candidates
Douglas Sheridan is a co-inventor of five clinical drug candidates targeted at treating rare diseases. His work also includes one approved drug for the treatment of multiple complement-related disorders, which has been sanctioned in the U.S., EU, and Japan. These achievements highlight his significant contributions to the field of pharmaceuticals and rare disease treatment.
Douglas Sheridan Role at Alexion Pharmaceuticals
Previously, Douglas Sheridan served as Executive Director, Global Program Team Leader, at Alexion Pharmaceuticals. In this role, he led cross-functional teams in the development of drug-device combination products. His leadership in these projects underscores his expertise in drug development and his capability in managing complex, multidisciplinary teams.
Douglas Sheridan Personal Interests and Beliefs
Douglas Sheridan enjoys hiking with his dog, Rosie, and values time spent outdoors. He believes that he has never had a good idea while sitting at a desk, highlighting his preference for outdoor brainstorming. Additionally, Douglas restored antique furniture professionally from age 19 to 27 before pursuing higher education, a period he describes as the most difficult challenge he has ever faced.